This Paper Deserves an Award for its Humble Approach to Bold Ideas.

Feedback is New Scientist A popular source for those seeking the latest in science and technology news. To share your thoughts on topics that may interest our readers, please send an email to feedback@newscientist.com.

Speaking Our Truth

Expert science journalists often learn to skim specific sections of scientific papers, particularly those asserting that the research signifies a “significant advancement” or “broadens understanding.” This isn’t because they are inaccurate, but because nearly any research yielding results can make these assertions, and academics are motivated (as we all are) to amplify the significance of their work.

But sometimes, it isn’t a hassle. Following a chain of events initiated by reporter Matthew Sparks and shared on the social platform Bluesky, Feedback uncovered a 2018 paper on the arXiv preprint server that would have claimed the prize for “most honest” research effort. Absolute refusal to make grand claims.

In this study, authors Joseph Redmon and Ali Farhadi detailed the latest iteration of YOLO, an AI framework designed to recognize objects in images. YOLO has even outperformed CAPTCHA tests requiring users to identify all squares containing bicycles and has been utilized to detect smuggling vessels. All said, these achievements are truly impressive (though perhaps alarming), but by 2018, the duo had evidently been coasting.

The title of their paper itself—”YOLOv3: Incremental Improvements”—is telling. The brief summary echoes this sentiment, stating, “we’ve implemented several minor design adjustments to enhance performance.” The essence can be distilled to: ‘You’ve contacted me year-round, yet my research efforts this year were sparse; much of my time was spent on Twitter.’ This line is, in fact, the date noted in the paper.

The authors further admit that the “improvements” largely stemmed from “good ideas taken from others.” They dive into details, first confessing that their tweaks are “not particularly exciting—just a collection of minor updates to enhance functionality.”

They then transition to Section 4, titled “Things I Tried That Didn’t Work.” This section, Feedback argues, should be a standard inclusion in all scientific publications, potentially saving others considerable time.

Despite acknowledging that they only recounted “what we recall,” they do remember an attempt involving something called “focal loss,” which ended up diminishing the model’s accuracy. “YOLOv3 might already be resilient to the focal loss problem, as it differentiates objectness prediction and conditional class prediction, resulting in minimal accuracy loss in most cases. Or maybe not? I’m not entirely sure,” they commented.

Feedback: I must have overlooked this in 2018, or I can’t believe I missed it when the article was spotlighted. Aggregator site Reddit played a role, but thanks to sociologist Per Angel, who mentioned in Bluesky:the restrictions section is a space for academics to practice radical honesty in just one paragraph. Data scientist Johan Ugander remarked that the YOLOv3 paper “deserves an accolade.” A truly candid piece.

Surely, there’s an academic somewhere known for their radical honesty regarding their minimal accomplishments. I’ll send an email to the usual address.

A Touch of Longevity

Clare Boyes once stated: “I understand you steer clear of prescriptive determinism, but I felt compelled to forward you this email I received today from the British Wildlife Newsletter.” It mentioned a book titled Tree Hunting: 1,000 Trees to Find in Towns and Cities Across the UK and Ireland, authored by Paul Wood.

In a similar vein, Robert Master pointed out that a recent special issue titled “How to Live to 100” (TL;DR: Don’t Die) featured a longevity researcher named Paul Lazarus.

Sleep on This

A while back (in July), Feedback reported on receiving a press release staunchly defending the environmental sustainability of avocados, only to find it originated from the World Avocado Organization. We concluded that while these individuals may be correct, they surely operate under a peculiar incentive structure.

We received no additional information from the avocado vendor, but we were inundated with press releases emphasizing the significance of sleep. “Struggling to find a solution? Science confirms that sleeping on it genuinely resolves your issues,” the first message proclaimed. It highlighted “exciting new research” and asserted that “the traditional advice to sleep on things may actually be one of the most effective problem-solving strategies available.”

This is attributed to the brain’s ability to continue processing memories and forging new connections while we sleep, occasionally leading to innovative insights through the amalgamation of new and old concepts. There was talk of memory consolidation, the prefrontal cortex (often seen as the brain’s inner critic), and associative thinking.

The follow-up email delved even further with a dramatic, albeit grammatically questionable, title: “New Study Indicates Rising Mortality Among Young Adults, Experts Warn Continued Sleep Deprivation Could Aggravate This.” The press release linked sleep deprivation with chronic health issues. There was also a quote from a “certified sleep coach”—possibly real?—but our minds conjured an image of a sweaty man in a tracksuit, whistle in hand, shouting, “Give me seven [hours]!” Yet the message remained clear: “Prioritize sleep.”

While it may have been foreshadowing, if you weren’t prepared for it, both emails, of course, came from mattress supplier Amerisleep.

Have a story for Feedback?

You can send your article to Feedback at feedback@newscientist.com. Please include your home address. This week’s and previous feedback can be accessed on our website.

Source: www.newscientist.com

A doctor explains if this fluffy mushroom truly deserves the title of ultimate superfood

If you’ve been browsing the internet recently, you’ve likely come across advertisements for Lionsman Mushroom supplements that claim to enhance health and prevent illness. But are these claims and products scientifically supported, or are they just a passing trend?


What exactly is a Lionsman mushroom?

The lion’s mane mushroom, scientifically known as Yamabushitake mushroom, is a sizable, hairy edible mushroom with a sweet taste and soft texture. It is used in gourmet cuisine and has a lengthy history in traditional medicine, attracting attention from both Western scientists and modern marketers.

There have been numerous studies on Lionsman mushrooms, with at least 410 research papers published in the last decade. However, only about a quarter of these studies have been conducted on humans, with the rest utilizing model systems like rodents or cell cultures. There have been a total of seven human clinical trials to date.

Is Yamabushitake good for your health?

Heart Health

Around one in three adults in the UK suffers from high blood pressure, and elevated cholesterol levels increase the risk of cardiovascular diseases. Lionsman extract has been studied for its potential to improve blood lipid levels, reduce oxidation, and possibly act as an anticoagulant.

Diabetes

Research suggests that Lionsman mushrooms may help control blood sugar levels, but this has only been demonstrated in rodents and cell studies, not in humans, especially those with diabetes.

Cancer Prevention

Studies have identified substances in lion’s mane mushrooms that may inhibit the growth of various cancer cells. However, more research is needed to determine if these effects translate to human consumption.

Mental Health and Cognition

Studies have shown that Lionsman extract can promote nerve cell growth, reduce oxidation and inflammation, and improve brain health. Small-scale studies have indicated potential benefits for memory and cognitive function.

Immunity and Inflammation

Lionsman compounds have been shown to have antioxidant and anti-inflammatory properties, but their effects on immunity in humans are yet to be fully understood.

Supports Gastrointestinal Health

Lionsman mushrooms have shown promise in limiting the growth of harmful bacteria and reducing the severity of gastrointestinal disorders in animal models. Human studies are still ongoing to confirm these effects.

So, can Lionsman mushroom supplements be beneficial for humans?

Most Lionsman products on the market focus on extracts, capsules, and powders, as these are easier to study than the whole mushroom. Dosage recommendations are challenging to determine due to the variability in products and the lack of conclusive data.

Are there any side effects?

Lionsman supplements are generally well-tolerated but may cause gastrointestinal upset, nausea, and skin rashes. It is important to consult with a healthcare provider before taking them, especially if you are on other medications.

Source: www.sciencefocus.com